GYN LIGHT

GOAL

Evaluation of the feasibility and efficacy of photobiomodulation therapy in the prevention and management of radiotherapy-induced vaginal toxicity

STUDY DESIGN

Multi-centric and controlled trial with endometrial cancer patients undergoing radiotherapy in the Jessa Hospital (Hasselt) or Ziekenhuis Oost-Limburg (Genk). This study started in February 2022.

PBM group (n=31)	Control group ​(n=31)
Standard vaginal care and intravaginal PBM (2x/week) during their radiotherapy and until two weeks post radiotherapy	Standard vaginal care

STUDY RESULTS

Study is still active and no preliminary results are available.

PUBLICATIONS

 

PARTNERS